Rhenman & Partners Asset Management AB decreased its position in shares of Immunovant, Inc. (NASDAQ:IMVT – Free Report) by 12.0% during the 4th quarter, HoldingsChannel.com reports. The fund owned 146,061 shares of the company’s stock after selling 20,000 shares during the period. Rhenman & Partners Asset Management AB’s holdings in Immunovant were worth $6,154,000 at […]
Insider Selling: Immunovant, Inc (NASDAQ:IMVT) Insider Sells 3,247 Shares of Stock theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Immunovant, Inc. (NASDAQ:IMVT – Free Report) – Stock analysts at Zacks Research increased their FY2024 earnings estimates for shares of Immunovant in a research note issued on Thursday, April 25th. Zacks Research analyst E. Bagri now expects that the company will post earnings of ($1.72) per share for the year, up from their prior forecast […]
Immunovant, Inc. (NASDAQ:IMVT – Get Free Report) insider Julia G. Butchko sold 10,115 shares of the business’s stock in a transaction dated Wednesday, April 17th. The shares were sold at an average price of $29.06, for a total value of $293,941.90. Following the completion of the transaction, the insider now directly owns 451,627 shares in […]
Immunovant, Inc. (NASDAQ:IMVT – Get Free Report) was the target of a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 9,350,000 shares, an increase of 7.7% from the February 29th total of 8,680,000 shares. Based on an average daily volume of 1,320,000 shares, the […]